Patient Guide: Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 62 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05222555
Status: ACTIVE_NOT_RECRUITING
Condition: Diffuse Large B Cell Lymphoma
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 62 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Morristown, New Jersey
  • Dallas, Texas
  • Olympia, Washington
  • • And 59 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily